Accessing innovative treatments in Europe: Managed entry/ risk sharing schemes for pharmaceuticals
The Early Access to Medicines Scheme (EAMS) in the UK
Date
08 Oct 2016Session
Accessing innovative treatments in Europe: Managed entry/ risk sharing schemes for pharmaceuticalsPresenters
Daniel O'ConnorAuthors
D. O'ConnorAuthor affiliations
- Medicines and Healthcare products Regulatory Agency, London/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction to Managed Entry Schemes
Presenter: Panos Kanavos
Session: Accessing innovative treatments in Europe: Managed entry/ risk sharing schemes for pharmaceuticals
Resources:
Slides
Webcast
The Dutch experience: DMTR
Presenter: Michel Wouters
Session: Accessing innovative treatments in Europe: Managed entry/ risk sharing schemes for pharmaceuticals
Resources:
Slides
Webcast
Patient advocacy involvement
Presenter: Violeta Astratinei
Session: Accessing innovative treatments in Europe: Managed entry/ risk sharing schemes for pharmaceuticals
Resources:
Slides
Webcast
Discussion: How to get involved
Presenter: Bettina Ryll
Session: Accessing innovative treatments in Europe: Managed entry/ risk sharing schemes for pharmaceuticals
Resources:
Webcast